Clinical Trial Update: High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a high oral loading dose of cholecalciferol (vitamin D3) in non-alcoholic fatty liver disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Tanta University | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED